Socrodeucitinib

Description

Socrodeucitinib Compound Example 58 is an orally active and selective tyrosine kinase 2 TYK2 inhibitor with an IC50 value of 1.41 nM. Socrodeucitinib exerts anti-inflammatory activity by inhibiting TYK2-mediated cytokine signaling pathways and reducing the secretion of inflammatory factors. Socrodeucitinib is promising for research of autoimmune diseases such as psoriasis and inflammatory diseases.